Before trying to rewind the clock on aging, the best longevity approach for the most people may be preventing and treating ...

It took years and major changes in how gene therapies are delivered for the field to recover. And now, 27 years after ...

Advanced non-viral gene delivery systems are expanding the range of indications and therapy modalities possible for the new generation of genetic medicines.

End-to-end pipelines and regulatory advances aim to expand gene editing to broad patient populations Ajay Gannerkote, ...

Department of GRI professor Debra Harry, Ph.D has been inducted into the American Academy of Arts and Sciences on behalf of ...

The company recently initiated a rolling BLA submission to the FDA seeking approval for lonvo-z as a one-time treatment for hereditary angioedema.

The American Chemical Society Committee on Meetings and Expositions (M&E) is responsible for the meetings function of ACS and ...

Intellia Therapeutics has reported the first-ever phase 3 results with an in vivo gene-editing therapy, hereditary angioedema (HAE) therapy lonvoguran ziclumeran (lonvo-z), and moved ahead straight ...

As cell and gene therapy leaders gathered in Maryland to discuss accelerating clinical trials in children, one “cutting edge” session focused on the need to expedite more bespoke gene editing ...

As co-founder and CEO of Algen Biotechnologies, Chun-Hao Huang merges genetic engineering and artificial intelligence to pioneer sustainable drug development.

Death comes for all of us. Even the tech bros like Mark Zuckerberg and Peter Thiel. The difference? Some are spending millions of dollars trying to ward off death as long as possible. And plenty of ...

This content was paid for by an advertiser and created by The Daily Tar Heel's marketing agency. The Daily Tar Heel newsroom was not involved in creating this content. As the Oliver Smithies Nobel ...